Clinical trial

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

NCT01432457

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention desvenlafaxine succinate sustained-release 50 mg/day Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention desvenlafaxine succinate sustained-release 100 mg/day Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-10-01

PhasePHASE4

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

desvenlafaxine succinate sustained-release 50 mg/dayDRUG

desvenlafaxine succinate sustained-release 100 mg/dayDRUG

placeboDRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

FargoNorth Dakota, United States3 New YorkNew York, United States2 DallasTexas, United States2 AtlantaGeorgia, United States2 San DiegoCalifornia, United States2 PortlandOregon, United States2 PhoenixArizona, United States2 HoustonTexas, United States1 PhiladelphiaPennsylvania, United States1 BaltimoreMaryland, United States1 SeattleWashington, United States1 CincinnatiOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01432457 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.